Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
about
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journalsMultilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.Failure or success of electronic search strategies to identify adverse effects data.Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.Study protocol: precision of a protocol for manual intramuscular needle placement checked by passive stretching and relaxing of the target muscle in the lower extremity during BTX-A treatment in children with spastic cerebral palsy, as verified by mFocal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects.Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.EFNS guidelines on diagnosis and treatment of primary dystonias.Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.Therapeutic use of botulinum toxin in neurorehabilitation.Use of botulinum toxin A in management of children with cerebral palsy.Clinical Management of Dystonia in Childhood.The performance of adverse effects search filters in MEDLINE and EMBASE.Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.Botulinum neurotoxin treatment in children with cerebral palsy: validation of a needle placement protocol using passive muscle stretching and relaxing.Delayed Hypersensitivity Reaction to OnabotulinumtoxinA
P2860
Q24197568-C73D20E9-60DF-40E9-916F-ADB334D314BFQ33967822-7899EF2A-F4EF-4974-B514-8757ECAE1793Q34238325-78A3DDAB-C603-4521-91A2-964917F5DB1EQ34371274-11732841-6355-4773-A795-69F681E30428Q34966160-B3676D6D-8215-47BF-904A-617BE0BCCBB6Q35880178-1602B9E7-1E63-418A-9C9C-F46E671C15EFQ36584801-75597B2C-1A57-4898-80EC-E14254B1B7AEQ36993876-EE5BC143-0694-4395-A335-9BCD56762231Q37337395-51F59992-E362-443F-AB26-E03181EE76E4Q37559858-E1BACC55-DF41-4185-BB18-7A4A26E8FFCDQ37756221-8CD669EC-6C72-4865-B20F-CEC79A328878Q38130567-E7296EE5-1D18-427B-86BC-95297DFC79AEQ38211279-07577A54-1D8A-4A0E-B6E5-C2542B88D297Q38414925-328A1E83-6CD2-44D3-B6ED-40BF426FF1DDQ38428227-1D95F931-B2B1-430D-B3C2-31CFF74BCCF2Q39377592-16068205-F1F8-4E64-83B1-25D9A8256785Q44546996-5F982D48-8930-4440-B2AE-C76E2212BD9DQ47151130-BAE23501-E849-4E63-9FD5-686A806A37A6Q47412154-D162AFD7-CEF5-4C33-878C-888DB1D0CC04Q58575613-63BB6C4A-FBED-4F9B-A96D-CDE257CC09C8
P2860
Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of botulinum toxin type ...... of randomized clinical trials.
@en
Safety of botulinum toxin type ...... of randomized clinical trials.
@nl
type
label
Safety of botulinum toxin type ...... of randomized clinical trials.
@en
Safety of botulinum toxin type ...... of randomized clinical trials.
@nl
prefLabel
Safety of botulinum toxin type ...... of randomized clinical trials.
@en
Safety of botulinum toxin type ...... of randomized clinical trials.
@nl
P2093
P2860
P356
P1476
Safety of botulinum toxin type ...... of randomized clinical trials.
@en
P2093
Alvaro J Idrovo
Cidronio Albavera-Hernández
Jorge M Rodríguez
P2860
P304
P356
10.1177/0269215508099860
P577
2009-04-23T00:00:00Z